Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension?

Journal of Clinical Endocrinology and Metabolism

Volumn 82, Issue 4, 1997, Pages 1047-1053

  López Velasco, Rosario ^a   Escobar Morreale, Héctor F ^a   Vega, Belén ^a   Villa, Eduardo ^a   Sancho, José M ^a   Moya Mur, José Luis ^a   García Robles, Rafael ^a  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOCARDIOGRAPHY; ENDOCRINE DISEASE; ESSENTIAL HYPERTENSION; FEMALE; GROWTH HORMONE RELEASE; HEART INDEX; HUMAN; MALE; PRIORITY JOURNAL;

ACROMEGALY; ADULT; CARDIOMYOPATHIES; CROSS-SECTIONAL STUDIES; DIASTOLE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEART; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; SYSTOLE;

EID: 0030904951     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.82.4.1047     Document Type: Article

References (39)

1. Nabarro JD. 1987 Acromegaly. Clin Endocrinol (Oxf). 26:481-512.
2. Alexander L, Appleton D, Hall R, Ross WM, Wilkinson R. 1980 Epidemiology of acromegaly in the Newcastle region. Clin Endocrinol (Oxf). 12:71-79.
3. Bengtsson B, Edén S, Ernest I, Odén A, Sjögren B. 1988 Epidemiology and long-term survival in acromegaly. Acta Med Scand. 223:327-335.
4. Seely EW, Williams GH. 1990 The cardiovascular system and endocrine disease. In: Becker KL, ed. Principles and practice of endocrinology and metabolism. Philadelphia: Lippincott; 1496-1503.
5. Hayward RP, Emanuel RW, Nabarro JD. 1987 Acromegalic heart disease: influence of treatment of the acromegaly on the heart. Q J Med. 62:41-58.
6. Rossi L, Thiene G, Caregaro L, Giordano R, Lauro S. 1977 Dysrhytmias and sudden death in acromegalic heart disease. A clinicopathologic study. Chest. 72:495-498.
7. Smalridge RC, Rajfer S, Davis J, Schaaf M. 1979 Acromegaly and the heart. Am J Med. 66:22-27.
8. Bertoni PD, Morandi G. 1987 Impaired left ventricular diastolic function in acromegaly: an echocardiographic study. Acta Cardiol. 42:1-10.
9. Hradec J, Marek J, Kral J, Janota T, Poloniecki J, Malik M. 1993 Long-term echocardiographic follow-up of acromegalic heart disease. Am J Cardiol. 72:205-210.
10. Baldwin A, Cundy T, Butler J, Timmis AD. 1985 Progression of cardiovascular disease in acromegalic patients treated by external pituitary irradiation. Acta Endocrinol (Copenh). 108:26-30.
11. 4th Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 148:1023-1038.
12. Sahn DJ, De Maria A, Kisslo J, Weyman A. 1978 The committee on M-mode standardization of the American Society of Echocardiography. Recommendations regarding quantification in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation. 58:1072-1083.
13. Devereux RB. 1987 Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization and comparison to other methods. Hypertension. 9(Suppl 2):II19-26.
14. Reicheck N, Wilson J, St John Sutton M, Plappert TA, Goldberg S, Hirshfeld JW. 1982 Non-invasive determination of left ventricular end-systolic stress: validation of the method and initial application. Circulation. 65:99-108.
15. Dawson-Saunders B, Trapp RG. 1990 Basic and clinical bioestatistics. East Norwalk: Appleton and Lange.
16. Kleinbaum DG, Kupper LL, Muller KE. 1988 Applied regression analysis and other multivariable methods. Boston: PWS-Kent.
17. Huchard H. 1895 Anatomie pathologique, lesions et troubles cardiovasculaires de l'acromegalie. J Practiciens. 9:249-250.
18. Bertoni PD, Morandi G. 1987 Impaired left ventricular diastolic function in acromegaly: an echocardiographic study. Acta Cardiol. 42:1-10.
19. Rodrigues EA, Caruana MP, Lahiri A, Nabarro JD, Jacobs HS, Raftery EB. 1989 Subclinical cardiac dysfunction in acromegaly: evidence for a specific disease of heart muscle. Br Heart J. 62:185-194.
20. Hradec J, Marek J, Petrasek J. 1988 The nature of cardiac hypertrophy in acromegaly: an echocardiographic study. Cor Vasa. 30:186-199.
21. Lusiani L, Ronsisvalle G, Visona A, et al. 1988 Acromegalic cardiomyopathy. An echocardiographic study. J Endocrinol Invest. 11:159-164.
22. Lacka K, Piszczek I, Kosowicz J, Gembicki M. 1988 Echocardiographic abnormalities in acromegalic patients. Exp Clin Endocrinol. 91:212-216.
23. Morvan D, Komajda M, Grimaldi A, Turpin G, Grosgogeat Y. 1991 Cardiac hypertrophy and function in asymptomatic acromegaly. Eur Heart J. 12:666-672.
24. Fazio S, Cittadini A, Sabatini D, et al. 1993 Evidence for biventricular involvement in acromegaly: a Doppler echocardiographic study. Eur Heart J. 14:26-33.
25. Fazio S, Cittadini A, Cuocolo A, et al. 1994 Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J Clin Endocrinol Metab. 79:441-446.
26. Cuocolo A, Nicolai E, Fazio S, et al. 1995 Impaired left ventricular diastolic filling in patients with acromegaly: assessment with radionuclide angiography. J Nucl Med. 36:196-201.
27. Giustina A, Boni E, Romanelli G, Grassi V, Giustina G. 1995 Cardiopulmonary performance during exercise in acromegaly, and the effects of acute suppression of growth hormone hypersecretion with octreotide. Am J Cardiol. 75:1042-1047.
28. Thuesen L, Christensen SE, Weeke J, Orskov H, Henningsen P. 1988 A hyperkinetic heart in uncomplicated active acromegaly. Explanation of hypertension in acromegalic patients? Acta Med Scand. 223:337-343.
29. Rossi E, Zuppi P, Pennestri F, et al. 1992 Acromegalic cardiomyopathy. Left ventricular filling and hypertrophy in active and surgically treated disease Chest. 102:1204-1208.
30. Lim MJ, Barkan AL, Buda AJ. 1992 Rapid reduction of left ventricular hypertrophy in acromegaly after suppression of growth hormone hypersecretion. Ann Intern Med. 117:719-726.
31. Thuesen L, Christensen SE, Weeke J, Orskov H, Henningsen P. 1989 The cardiovascular effects of octreotide treatment in acromegaly: an echocardiographic study. Clin Endocrinol (Oxf). 30:619-625.
32. Pereira JL, Rodriguez Puras MJ, Leal Cerro A, et al. 1991 Acromegalic cardiopathy improves after treatment with increasing doses of octreotide. J Endocrinol Invest. 14:17-23.
33. Merola B, Cittadini A, Colao A, et al. 1993 Chronic treatment with the somatostatin analog octreotide improves cardiac abnormalities in acromegaly. J Clin Endocrinol Metab. 77:790-793.
34. Gilbert PL, Siegel RJ, Melmed S, Sherman CT, Fishbein MC. 1985 Cardiac morphology in rats with growth hormone-producing tumours. J Mol Cell Cardiol. 17:805-811.
35. Lie JT, Grossman SJ. 1980 Pathologhy of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am Heart J. 100:41-52.
36. Dilley RJ, Schwartz SM. 1989 Vascular remodelling in the growth hormone transgenic mouse. Circ Res. 65:1233-1240.
37. Moore TJ, Thein-Wai W, Dluhy RG, Dawson-Hughes BF, Hollenberg NK, Williams GH. 1980 Abnormal adrenal and vascular responses to angiotensin II and an angiotensin antagonist in acromegaly. J Clin Endocrinol Metab 51:215-222.
38. Ludens GH, Back RR, Williamsen HE. 1969 Characteristics of the antinatriuretic action of growth hormone. Proc Soc Exp Biol Med. 130:1156-1158.
39. Diez J, Laviades C. 1994 Insulin-like growth factor-1 and cardiac mass in essential hypertension: comparative effects of captopril, lisinopril and quinapril. J Hypertens. 12(Suppl 4):S31-S36.